[Criteria for the clinical evaluation of antimicrobial drugs in neonates].
作者信息
Fujii R, Sato Y, Kobayashi H, Nishimura T, Sunagawa K, Iwata K, Meguro E, Toyonaga Y, Akita H, Iwai N, Motohiro K, Sato H
出版信息
Jpn J Antibiot. 1996 Jul;49(7):743-53.
PMID:8828074
Abstract
摘要
相似文献
1
[Criteria for the clinical evaluation of antimicrobial drugs in neonates].[新生儿抗菌药物临床评价标准]
Jpn J Antibiot. 1996 Jul;49(7):743-53.
2
[A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia].
Antibiot Khimioter. 2000;45(1):39-44.
3
Iseganan. IB 367, protegrin IB 367.异塞加南。IB 367，防御素IB 367。
Drugs R D. 2002;3(1):52-5. doi: 10.2165/00126839-200203010-00012.
4
[Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity].司帕沙星（一种长效二氟喹诺酮类药物）——一种具有广谱抗菌活性的制剂
Antibiot Khimioter. 2002;47(1):26-35.
5
[Comparative clinical and bacteriological studies with Bactrim and ampicillin in the pediatrics].[小儿科中复方新诺明与氨苄青霉素的临床与细菌学对比研究]
Schweiz Rundsch Med Prax. 1972 Aug 15;61(33):1051-2.
6
An audit of ciprofloxacin use in severe life threatening infection at the AKUH.对阿迦汗大学医院（AKUH）中使用环丙沙星治疗严重危及生命感染情况的一项审计。
J Pak Med Assoc. 1996 Jan;46(1):25-7.
7
8
The choice of antimicrobial drugs.抗菌药物的选择。
Med Lett Drugs Ther. 1984 Mar 2;26(656):19-26.
9
Evaluation of new anti-infective drugs for the treatment of intraabdominal infections. Infectious Diseases Society of America and the Food and Drug Administration.用于治疗腹腔内感染的新型抗感染药物评估。美国传染病学会和美国食品药品监督管理局。
Clin Infect Dis. 1992 Nov;15 Suppl 1:S33-42. doi: 10.1093/clind/15.supplement_1.s33.
10
[Advances in pharmacokinetic studies and clinical use of antibiotics and various chemotherapeutic agents in children].
Pediatr Pol. 1988 Jun;63(6):397-404.
Zotero 插件